Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

4 Nov 2014 07:00

RNS Number : 0460W
Persimmon PLC
04 November 2014
 



INTERIM MANAGEMENT STATEMENT

 

TUESDAY 4 NOVEMBER 2014

 

 

Persimmon plc today releases its third quarter Interim Management Statement which covers the period from 1 July 2014 to 3 November 2014.

 

We remain encouraged by the level of customer confidence in the UK housing market. Visitor levels have matched those of the prior year despite the tough comparatives generated by the strong growth in interest on our sites following the Government's introduction of the Help to Buy measures in April 2013.

 

As expected we have experienced a return to a more traditional seasonal pattern to customer activity this year with reservation rates picking up with the onset of the autumn season after the slower summer weeks.

 

As is usual at this point in the year we are now fully sold up for 2014 with limited further stock availability for the current year. However, we continue to experience good forward reservation interest and have c. £696 million of forward sales reserved beyond 2014, an increase of 12% on the same point last year (2013: £622 million).

 

All of the Group's twenty-four businesses across the UK remain focussed on maximising the value of every new home sale. This tried and tested approach is delivering the superior margins and cash generation which are at the core of our long term strategy. Selling prices remain robust with modest growth available in areas of higher demand, and particularly when new sites are successfully launched. With cancellation rates running at the historically low levels we have been experiencing for some time, our private sale reservation rates are c. 2% lower than those for the same period last year, notwithstanding the tougher comparatives which were c. 45% ahead of 2012.

 

Despite the ongoing improvements to the planning system, opening new development sites without undue delay continues to be one of the industry's main constraints. Whilst we have successfully opened 80 of the 100 new sites planned for the second half of the year, our desire to modestly increase our overall outlet numbers remains a challenge. We are currently selling homes from c.375 active development sites.

 

The recovery of the UK mortgage market continues to mature, providing improving support to customers whilst also ensuring the required disciplines are in place to support a more stable and sustainable outlook for the housing market.

 

The delivery of the Group's long term strategy is dependent on investing in new replacement land both at the right time in the cycle and at values that will produce superior returns and cash generation over future years. The Group has continued to secure excellent sites totalling c. 7,500 plots of land since 1 July, with over 4,000 plots being converted from the Group's strategic land portfolio. At this point we remain keen to invest in high quality land to support the growth of the business towards optimal sustainable scale.

 

We remain confident of delivering further growth in Group operating profits in the second half of the year from both improved gross margins and tightly controlled overheads. With our new site openings, land recoveries continue to improve and with increased production volumes we are capturing further build efficiencies. Our Space4 new home timber frame factory continues to increase supply to the Group which is supporting a swifter response to the increase in market demand but is also becoming increasingly cost advantageous. We expect Space4 to deliver almost 5,500 frames to Group companies this year, an increase of c.30% year on year.

 

As a result of the continued disciplined growth of the business we expect a substantial level of cash holding by the year end (31 December 2013: £204.3 million) even after allowing for the ongoing significant investment in land and work in progress.

 

We will give a further update on progress and trading following the year end on Wednesday 7 January 2015.

 

Jeff Fairburn and Mike Killoran will host a conference call with analysts at 9.00 a.m. today.

To participate please dial +44 (0) 20 3003 2666 The password is "Persimmon".

 

 

For further information, please contact:

Persimmon plc

Tel: +44 (0)1904 642199

Jeff Fairburn, Group Chief Executive

Mike Killoran, Group Finance Director

Citigate Dewe Rogerson

Tel: +44 (0)20 7638 9571

Simon Rigby

Kevin Smith

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUOUWRSSAARAA
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.